Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: Blockade by inhibitors of mitogen-activated protein kinase- kinase and phosphatidyl inositol 3'-kinase

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 325-334

  Zheng, Xi Long ^a   Renaux, Bernard ^a   Hollenberg, Morley D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; THROMBIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; GUINEA PIG; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARACHIDONIC ACID; CALCIUM; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GUINEA PIGS; LIPOPROTEIN LIPASE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHOSPHATIDYLINOSITOLS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION;

EID: 0031978961     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. 2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 73:1203-1207.
2. Amin D, Sutherland CA, Khandwala AS, Jamall IS and Kapoor AL (1986) Inhibition of the effects of thrombin on guinea pig platelets by the diacylglycerol lipase inhibitor RHC 80267. Thrombosis Res 44:75-84.
3. Berk BC, Brock TA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MA, Jr and Alexander RW (1985) Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest 75:1083-1086.
4. Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J and Scarborough RM (1996) Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 271:16466-16471.
5. cdc2 is a specific and efficient substrate or src-family tyrosine kinases. J Biol Chem 267:9248-9256.
6. Cohen S (1962) Isolation of a mouse submaxilliary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1555-1562.
7. Coughlin SR, Vu T-KH, Hung DT and Wheaton VI (1992) Characterization of a functional thrombin receptor. J Clin Invest 89:351-355.
8. Daub H, Weiss FU, Wallasch C and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557-560.
9. 9,-bradykinin or of α-thrombin in rabbit aortic rings. Br J Pharmacol 105:959-967.
10. Dudley DT, Pang L and Saltiel AR (1995) A synthetic inhibitor of the mitogenactivated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7690.
11. Fry DW, Kraker AJ, Mcmichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW and Bridges AJ (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265:1093-1095.
12. Glenney JR, Jr, Zokas L and Kamps MP (1988) Monoclonal antibodies to phosphotyrosine. J Immunol Methods 109:277-285.
13. Gregory H (1975) Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 257:325-327.
14. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA and Connelly PA (1996) Discovery of a novel, potent, and src family-selective tyrosine kinase inhibitor. J Biol Chem 271:695-701.
15. Hollenberg MD, Muramatsu I, Itoh H, Patel P, Yang S-G and Lederis K (1989) Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: Structure-activity relationships and comparison with the effects of human transforming growth-factor alpha. J Pharmacol Exp Ther 248:384-390.
16. Hollenberg MD, Yang S-G, Laniyonu AA, Moore GJ and Saifeddine M (1992) Action of thrombin receptor polypeptide in gastric smooth muscle: Identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol Pharmacol 42:186-191.
17. Hollenberg MD (1994a) The acute actions of growth factors in smooth muscle systems. Life Sci 54:223-235.
18. Hollenberg MD (1994b) Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108-114.
19. Hollenberg MD (1996) Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol Sci 17:3-6.
20. Hollenberg MD, Saifeddine M, Al-Ani B and Kawabata A (1997) Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75:832-841.
21. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T and Coughlin SR (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506.
22. 2). Proc Western Pharm Soc 40: 49-51.
23. 4. Nature 227:680-685.
24. Laniyonu A, Saifeddine M, Ahmad S and Hollenberg MD (1994) Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br J Pharmacol 113:403-410.
25. Lopez-Llasaca M, Crespo P, Pellici PG, Gutkind JS and Wetzker R (1997) Linkage of G-protein-coupled receptors to the MAPK signalling pathway through PI-3 kinases. Science 275:394-397.
26. Luttrell LM, Hawes BE, Van Biesen T, Luttrell DK, Lansing TJ and Lefkowitz RJ (1996) Role of C-Src tyrosine kinase in G-protein-coupled receptor-and Gbeta-gamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271:19443-19450.
27. Luttrell LM, Della Rocca GJ, Van Biesen T, Luttrell DK and Lefkowitz RJ (1997) Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor. J Biol Chem 272:4637-4644.
28. Muramatsu I, Hollenberg MD and Lederis K (1985) Vascular actions of epidermal growth factor-urogastrone: Possible relationship to prostaglandin production. Can J Physiol Pharmacol 63:995-999.
29. Muramatsu I, Itoh H, Lederis K and Hollenberg MD (1988) Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach; differential inhibition by indomcthacin. J Pharmacol Exp Ther 245:625-631.
30. Muramatsu I, Laniyonu AA, Moore GJ and Hollenberg MD (1992) Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol 70:996-1103.
31. Nystedt S, Emilsson K, Wahlested C and Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
32. Nystedt S, Larsson A-K, Aberg H and Sundelin J (1995) The mouse proteinase-activated receptor-2 cDNA and gene. J Biol Chem 270:5950-5955.
33. Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A and Saltiel AR (1994) Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. J Biol Chem 269:3783-3788.
34. Pleiman CM, Hertz WMA and Cambier JC (1994) Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263: 1609-1612.
35. 2+ mobilization. FEBS Lett 288:123-128.
36. Simonet S, Bonhomme E, Laubie M, Thurieau C, Fauchere J-I and Verveuren TJ (1992) Venous and arterial endothelial cells respond differently to thrombin and its endogenous receptor agonist. Eur J Pharmacol 216:135-137.
37. 2 and diglyceride lipase. J Biol Chem 257:14006-14010.
38. Toker A and Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676.
39. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E and Loriolle FA (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
40. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno KA and Ohno S (1996) Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent of Raf. J Biol Chem 271:23512-23519.
41. Ui M, Okada T, Hazeki K and Hazeki O (1995) Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 20:303-307.
42. Vu T-KH, Hung DT, Wheaton VI and Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
43. Yang, S-G, Saifeddine M, Chuang M, Severson DL and Hollenberg MID (1991) Diacylglycerol lipase and the contractile action of epidermal growth factor-urogastrone evidence for distinct signal pathways in a single strip of gastric smooth muscle. Eur J Pharmacol Mol Pharmacol Sec 207:225-230.
44. Yang S-G, Laniyonu AA, Saifeddine M, Moore GJ and Hollenberg MD (1992a) Actions of thrombin and thrombin receptor peptide analogues in gastric and aortic smooth muscle: Development of bioassays for structure-activity studies. Life Sci 51:1325-1332.
45. Yang S-G, Saifeddine M and Hollenberg MD (1992b) Tyrosine kinase inhibitors and the contraction action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can J Physiol Pharmacol 70:85-93.
46. Yang S-G, Saifeddine M, Laniyonu A and Hollenberg MD (1993) Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: Differential blockade by indomethacin and tyrosine kinase inhibitors, J Pharmacol Exp Ther 264:958-966.
47. Zheng X-L and Hollenberg MD (1997) Dependence of thrombin receptor-mediated contraction of guinea pig gastric smooth muscle on growth factor signalling pathways: Comparison with EGF and implication of a role for Src-family kinases. Proc Western Pharm Soc 40: 45-48.
48. Zheng X-L, Mokashi S and Hollenberg MD (1997) Contractile action of ethanol in guinea pig gastric smooth muscle: Inhibition by tyrosine kinase inhibitors and comparison with the contractile action of epidermal growth factor-urogastrone. J Pharmacol. Exp Ther 282:485-495.